Your browser doesn't support javascript.
loading
High-Flow Oxygen and Other Noninvasive Respiratory Support Therapies in Bronchiolitis: Systematic Review and Network Meta-Analyses.
Gutiérrez Moreno, Miriam; Del Villar Guerra, Pablo; Medina, Alberto; Modesto I Alapont, Vicent; Castro Bournissen, Leandro; Mirás Veiga, Alicia; Ochoa-Sangrador, Carlos.
Afiliação
  • Gutiérrez Moreno M; Department of Paediatrics, Complejo Asistencial de Zamora, Zamora, Spain.
  • Del Villar Guerra P; Department of Paediatrics, Hospital Universitario Río Hortera de Valladolid, Valladolid, Spain.
  • Medina A; Pediatric Intensive Care Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Modesto I Alapont V; Pediatric Intensive Care Unit, Hospital Universitario La Fe de Valencia, Valencia, Spain.
  • Castro Bournissen L; Department of Intensive Medicine, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.
  • Mirás Veiga A; Department of Paediatrics, Hospital Universitario de Burgos, Burgos, Spain.
  • Ochoa-Sangrador C; Department of Paediatrics, Complejo Asistencial de Zamora, Zamora, Spain.
Pediatr Crit Care Med ; 24(2): 133-142, 2023 02 01.
Article em En | MEDLINE | ID: mdl-36661419
ABSTRACT

OBJECTIVES:

We present a systematic review on the effectiveness of noninvasive respiratory support techniques in bronchiolitis. DATA SOURCES Systematic review with pairwise meta-analyses of all studies and network meta-analyses of the clinical trials. STUDY SELECTION Patients below 24 months old with bronchiolitis who require noninvasive respiratory support were included in randomized controlled trials (RCTs), non-RCT, and cohort studies in which high-flow nasal cannula (HFNC) was compared with conventional low-flow oxygen therapy (LFOT) and/or noninvasive ventilation (NIV). DATA EXTRACTION Emergency wards and hospitalized patients with bronchiolitis. DATA

SYNTHESIS:

A total of 3,367 patients were analyzed in 14 RCTs and 8,385 patients in 14 non-RCTs studies. Only in nonexperimental studies, HFNC is associated with a lower risk of invasive mechanical ventilation (MV) than NIV (odds ratio, 0.49; 95% CI, 0.42-0.58), with no differences in experimental studies. There were no differences between HFNC and NIV in other outcomes. HFNC is more effective than LFOT in reducing oxygen days and treatment failure. In the network meta-analyses of clinical trials, NIV was the most effective intervention to avoid invasive MV (surface under the cumulative ranking curve [SUCRA], 57.03%) and to reduce days under oxygen therapy (SUCRA, 79.42%), although crossover effect estimates between interventions showed no significant differences. The included studies show methodological heterogeneity, but it is only statistically significant for the reduction of days of oxygen therapy and length of hospital stay.

CONCLUSIONS:

Experimental evidence does not suggest that high-flow oxygen therapy has advantages over LFOT as initial treatment nor over NIV as a rescue treatment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bronquiolite / Ventilação não Invasiva Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Infant Idioma: En Revista: Pediatr Crit Care Med Assunto da revista: PEDIATRIA / TERAPIA INTENSIVA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bronquiolite / Ventilação não Invasiva Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Infant Idioma: En Revista: Pediatr Crit Care Med Assunto da revista: PEDIATRIA / TERAPIA INTENSIVA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha